Neurology company Promentis Pharmaceuticals Inc. (Milwaukee, Wisc.) raised $26 million in a series C round led by new investors OrbiMed, F-Prime Capital and Aisling Capital on March 30. Existing investors Black Pearl, the Golden Angel...